EBV-associated T/NK–cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases
Top Cited Papers
Open Access
- 19 January 2012
- journal article
- Published by American Society of Hematology in Blood
- Vol. 119 (3), 673-686
- https://doi.org/10.1182/blood-2011-10-381921
Abstract
EBV-associated T/NK–cell lymphoproliferative disease (T/NK-LPD) is defined as a systemic illness characterized by clonal proliferation of EBV-infected T or NK cells. We prospectively enrolled 108 nonimmunocompromised patients with this disease (50 men and 58 women; median onset age, 8 years; age range, 1-50 years) evidenced by expansion of EBV+ T/NK cells in the peripheral blood; these were of the T-cell type in 64 cases and of the NK-cell type in 44, and were clinically categorized into 4 groups: 80 cases of chronic active EBV disease, 15 of EBV-associated hemophagocytic lymphohistiocytosis, 9 of severe mosquito bite allergy, and 4 of hydroa vacciniforme. These clinical profiles were closely linked with the EBV+ cell immunophenotypes. In a median follow-up period of 46 months, 47 patients (44%) died of severe organ complications. During the follow-up, 13 patients developed overt lymphoma or leukemia characterized by extranodal NK/T-cell lymphoma and aggressive NK-cell leukemia. Fifty-nine received hematopoietic stem cell transplantation, 66% of whom survived. Age at onset of disease (≥ 8 years) and liver dysfunction were risk factors for mortality, whereas patients who received transplantation had a better prognosis. These data depict clinical characteristics of systemic EBV+ T/NK-LPD and provide insight into the diagnostic and therapeutic approaches for distinct disease.Keywords
This publication has 40 references indexed in Scilit:
- The 2008 WHO classification of lymphomas: implications for clinical practice and translational researchHematology-American Society Hematology Education Program, 2009
- HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosisPediatric Blood & Cancer, 2006
- Epstein-Barr virus: the impact of scientific advances on clinical practiceBlood, 2006
- Clinical and virologic characteristics of chronic active Epstein-Barr virus infectionBlood, 2001
- Epstein–Barr Virus InfectionNew England Journal of Medicine, 2000
- Fulminant EBV+ T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndromeBlood, 2000
- The association of latent Epstein?Barr virus infection with hydroa vacciniformeBritish Journal of Dermatology, 1999
- Clonal lymphoproliferation following chronic active Epstein-Barr virus infection and hypersensitivity to mosquito bitesAmerican Journal of Hematology, 1997
- T-Cell Lymphomas Containing Epstein–Barr Viral DNA in Patients with Chronic Epstein–Barr Virus InfectionsNew England Journal of Medicine, 1988
- The Chronic Mononucleosis SyndromeThe Journal of Infectious Diseases, 1988